Arvinas

Arvinas

2023年12月27日—Arvinasisaclinical-stagebiotechnologycompanydedicatedtoimprovingthelivesofpatientssufferingfromdebilitatingand ...。其他文章還包含有:「About」、「ArvinasandPfizerAnnounceGlobalCollaborationto...」、「Arvinas,Inc.(ARVN)StockPrice」、「Arvinas」、「OurScienceBehindTargetedProteinDegradation」、「PROTACProteinDegraderPipeline」、「ProteinDegradationwithPROTACProteinDegraders」、「...

查看更多 離開網站

Provide From Google
About
About

https://www.arvinas.com

Arvinas is focused on developing new options for patients in need, pioneering a new class of medicines to target and degrade disease-related proteins.

Provide From Google
Arvinas and Pfizer Announce Global Collaboration to ...
Arvinas and Pfizer Announce Global Collaboration to ...

https://www.pfizer.com

Arvinas and Pfizer will jointly develop ARV-471 through a robust clinical program designed to position ARV-471 as an endocrine backbone therapy ...

Provide From Google
Arvinas, Inc. (ARVN) Stock Price
Arvinas, Inc. (ARVN) Stock Price

https://finance.yahoo.com

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing ...

Provide From Google
Arvinas
Arvinas

https://www.arvinas.com

Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.

Provide From Google
Our Science Behind Targeted Protein Degradation
Our Science Behind Targeted Protein Degradation

https://www.arvinas.com

Invented by Arvinas, PROTAC® Targeted Protein Degraders harness the bodys natural protein disposal system and destroy disease-causing proteins.

Provide From Google
PROTAC Protein Degrader Pipeline
PROTAC Protein Degrader Pipeline

https://www.arvinas.com

Arvinas pipeline of PROTAC® protein degraders, are designed to harness the body's own natural protein disposal system.

Provide From Google
Protein Degradation with PROTAC Protein Degraders
Protein Degradation with PROTAC Protein Degraders

https://arvinasoncologymedical

Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.

Provide From Google
Research and Development
Research and Development

https://www.arvinas.com

Arvinas is currently the only targeted protein degradation company with investigational drugs nearing pivotal trials. Arvinas scientific ...

Provide From Google
蛋白降解技術藏商機?輝瑞聯手Arvinas 標靶轉移性乳癌
蛋白降解技術藏商機?輝瑞聯手Arvinas 標靶轉移性乳癌

https://geneonline.news

Arvinas 的醫療長指出,ARV-471 是目前臨床中標靶ER 最具潛力的療法,其ER 蛋白降解效力也比AstraZeneca(AZ)的fulvestrant 來得高。